60 http://clinicaloptions.com/oncology.aspx en-us ℗ & © 2006 Clinical Care Options CCO is your best source for the newest oncology treatment data. Clinical Care Options Audio highlights from independent conference coverage and other educational programs Clinical Care Options Oncology vkeane@clinicaloptions.com Clinical Care Options CCO Expert Highlights from the 2008 Clinical Oncology Meeting Hagop Kantarjian, MD, gives an overview of recent data on the introduction of novel agents into the treatment regimens for leukemias, myelodysplastic syndromes, and multiple myeloma. http://clinicaloptions.com/onc_podcast_audio_clinonc2008_heme.mp3 Wed, 02 Jul 2008 17:00:00 GMT 5:28 hematology, oncology, Kantarjian Clinical Care Options CCO Expert Highlights from the 2008 Clinical Oncology Meeting Kathy D. Miller, MD, provides an update on the top issues in adjuvant therapy including hormone therapy, bone loss treatments, and vitamin D status. She also discusses the impact of biologic agents targeting the VEGF and EGF receptors on therapy for metastatic disease. http://clinicaloptions.com/onc_podcast_audio_clinonc2008_breast.mp3 Mon, 7 Jul 2008 17:00:00 GMT 12:01 breast cancer, oncology, miller Clinical Care Options CCO Expert Highlights from the 2008 Clinical Oncology Meeting Ramaswamy Govindan, MD, examines the results of the phase III FLEX trial of cetuximab added to cisplatin/vinorelbine chemotherapy in advanced non-small-cell lung cancer along with other key clinical trial data presented in Chicago. http://clinicaloptions.com/onc_podcast_audio_clinonc2008_lung.mp3 Thu, 04 Jul 2008 17:00:00 GMT 08:09 lung cancer, oncology, Govindan Clinical Care Options CCO Expert Highlights from the 2008 Clinical Oncology Meeting Richard M. Goldberg, MD, reviews key developments in colorectal cancer, including new clinical trial results in adjuvant treatment and therapy of metastatic disease, and new insights into molecular markers for prediction of response to biologic therapy. http://clinicaloptions.com/onc_podcast_audio_clinonc2008_gastro.mp3 Tue, 01 Jul 2008 17:00:00 GMT 8:42 gastrointestinal cancers, oncology, Goldberg Clinical Care Options CCO Expert Highlights from the 2008 Clinical Oncology Meeting Brian I. Rini, MD, highlights the clinical advances being made for improving outcomes in patients with metastatic renal cell carcinoma, and prostate, bladder, and testicular cancers. http://clinicaloptions.com/onc_podcast_audio_clinonc2008_genitour.mp3 Fri, 27 Jun 2008 17:00:00 GMT 7:44 genitourinary cancer,oncology,Rini Clinical Care Options A Treatment Update from Clinical Care Options John L. Marshall, MD, discusses the latest treatment developments in gastrointestinal cancers, focusing on advances in the management of colorectal cancer, including new chemotherapeutic and biologic approaches, and also discussing emerging strategies in hepatocellular carcinoma, gastric and esophageal, and pancreatic cancers. http://clinicaloptions.com/onc_podcast_audio_gitreatment.mp3 Fri, 21 Mar 2008 17:00:00 GMT 56:18 gastrointestinal, cancer, Marshall Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Clifford A. Hudis, MD, highlights key studies including the promise of pharmacogenomics for patients with breast cancer in the metastatic setting. http://clinicaloptions.com/onc_podcast_audio_bc07_hudis.mp3 Wed, 23 Jan 2008 17:00:00 GMT 4:43 oncology, breast cancer, Hudis Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Sagar Lonial, MD, updates maturing clinical trial data in newly diagnosed and relapsed multiple myeloma patients and discusses emerging therapies. http://clinicaloptions.com/onc_podcast_audio_heme07_lonial.mp3 Fri, 18 Jan 2008 17:00:00 GMT 3:19 hematology, Multiple Myeloma, MML, Lonial Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Hagop M. Kantarjian, MD, provides an update on management of acute leukemias, including discussion of prognostic markers, optimal induction and maintenance therapies, and new agents. http://clinicaloptions.com/onc_podcast_audio_heme07_kantarjian.mp3 Tue, 15 Jan 2008 17:00:00 GMT 4:50 hematology, leukemia, Kantarjian Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Daniel F. Hayes, MD, discusses studies that focused on the benefits of tailoring patients to individualized therapy to be able to predict which patients will or will not benefit from chemotherapy or hormonal therapy. http://clinicaloptions.com/onc_podcast_audio_bc07_hayes.mp3 Tue, 8 Jan 2008 17:00:00 GMT 5:32 oncology, breast cancer, Hayes Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Moshe Talpaz, MD, describes the emerging data on the treatment of chronic myelogenous leukemia, with discussion of the use of tyrosine kinase inhibitors as well as response characteristics in this patient population. http://clinicaloptions.com/onc_podcast_audio_heme07_talpaz.mp3 Mon, 7 Jan 2008 17:00:00 GMT 5:42 hematology, chronic myelogenous leukemia, Talpaz Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Edith A. Perez, MD, reviews studies that highlighted molecular profiling in estrogen receptor-positive disease to determine if patients will benefit from chemotherapy. She also comments on the use of targeted therapies in the adjuvant setting. http://clinicaloptions.com/onc_podcast_audio_bc07_perez.mp3 Fri, 4 Jan 2008 17:00:00 GMT 2:52 oncology, breast cancer, Perez Clinical Care Options CCO Expert Highlights from the 2007 Breast Cancer Meeting Peter Ravdin, MD, describes the use of biomarkers and molecular tests and how those will help enhance clinical decisions for treating patients with early breast cancer. He also comments on the use of aromatase inhibitors in patients with early-stage breast cancer. http://clinicaloptions.com/onc_podcast_audio_bc07_ravdin.mp3 Thu, 3 Jan 2008 17:00:00 GMT 9:05 oncology, breast cancer, Ravdin Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Michael J. Keating, MB BS, gives an overview of new insights into the genetics, biology, and immunology of chronic lymphocytic leukemia and new advances in chemoimmunotherapy. http://clinicaloptions.com/onc_podcast_audio_heme07_keating.mp3 Wed, 2 Jan 2008 17:00:00 GMT 6:21 hematology, leukemia, Keating Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Alan F. List, MD, discusses the importance of dosing and scheduling of therapies in myelodysplastic syndrome, as well as the biology of the disease, supportive care and emerging treatments. http://clinicaloptions.com/onc_podcast_audio_heme07_list.mp3 Fri, 28 Dec 2007 17:00:00 GMT 5:08 hematology, myelodysplastic, List Clinical Care Options CCO Expert Highlights from the 2007 Hematology Meeting Julie M. Vose, MD, describes evolving strategies in the treatment of non-Hodgkin’s lymphoma and the incorporation of newer agents into therapy. http://clinicaloptions.com/onc_podcast_audio_heme07_vose.mp3 Wed, 26 Dec 2007 17:00:00 GMT 5:06 hematology, non-Hodgkin's lymphoma, Vose Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Clifford Hudis, MD, reviews the efficacy and safety data of ongoing clinical trials in both the adjuvant and metastatic breast cancer settings. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_hudis.mp3 Tue, 19 Jun 2007 17:00:00 GMT 11:46 Oncology, Breast Cancer, Hudis Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Everett Vokes, MD, highlights the emergence of new data on HPV and prognosis, the clinical importance of EGFR blockade, and treatment of iodine-refractory thyroid cancer. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_vokes.mp3 Fri, 15 Jun 2007 17:00:00 GMT 3:36 Oncology, HPV, Thyroid Cancer, Vokes Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Nicholas Vogelzang, MD, discusses results from recent clinical trials as well as exciting technological advances in detection and how these may impact patient outcomes for prostate cancer patients. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_vogelzang.mp3 Thu, 14 Jun 2007 17:00:00 GMT 6:03 Oncology, Prostate Cancer, Vogelzang Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago Alan P. Venook, MD, describes the most important findings in colorectal cancer, along with highlights from key presentations in pancreatic cancer, esophagogastric adenocarcinoma, and hepatocellular carcinoma. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_venook.mp3 Wed, 13 Jun 2007 17:00:00 GMT 9:47 Oncology, Colorectal Cancer, Venook Clinical Care Options CCO Expert Highlights from the Clinical Oncology Meeting in Chicago David Gandara, MD, emphasizes the importance of tumor biology in assessing better treatment choices for patients with SCLC and NSCLC. http://clinicaloptions.com/onc_podcast_audio_clinonc2007_gandara.mp3 Tue, 12 Jun 2007 17:00:00 GMT 2:54 Oncology, Lung Cancer, Gandara Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Nicholas J. Robert, MD, highlights clinical trial data and vaccine therapy in early stage breast cancer. http://clinicaloptions.com/onc_podcast_audio_bc06_targetedagents.mp3 Thu, 18 Jan 2007 17:00:00 GMT 5:15 breast cancer, vaccine, Robert Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Peter Ravdin, MD, PhD, discusses endocrine therapy strategies in the adjuvant setting. http://clinicaloptions.com/onc_podcast_audio_bc06_endocrine.mp3 Thu, 18 Jan 2007 17:00:00 GMT 4:42 breast cancer, adjuvant, Ravdin Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando John C. Byrd, MD, reviews maturing data on treatment of CLL, introduces early data on exciting new therapies in both front-line and relapsed/refractory settings, and discusses tools for better defining prognosis. http://clinicaloptions.com/onc_podcast_audio_heme06_byrd.mp3 Mon, 15 Jan 2007 17:00:00 GMT 4:37 hematology, leukemia, Byrd Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Hope S. Rugo, MD, reviews detection, prevention, and risk stratification data. http://clinicaloptions.com/onc_podcast_audio_bc06_detect.mp3 Fri, 12 Jan 2007 17:00:00 GMT 2:47 breast cancer, detection, Rugo Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Moshe Talpaz, MD, discusses appropriate positioning of therapies and ongoing controversies regarding bone marrow transplant for patients with CML. http://clinicaloptions.com/onc_podcast_audio_heme06_talpaz.mp3 Fri, 5 Jan 2007 17:00:00 GMT 6:02 hematology, CML, Talpaz Clinical Care Options CCO Expert Highlights from the Breast Cancer Meeting in San Antonio Clifford A. Hudis, MD, discusses emerging targeted therapies in the treatment of metastatic breast cancer. http://clinicaloptions.com/onc_podcast_audio_bc06_metastatic.mp3 Fri, 5 Jan 2007 17:00:00 GMT 6:34 breast cancer, metastatic, Hudis Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Julie M. Vose, MD, updates major clinical trial results in non-Hodgkin's lymphoma and presents emerging data on novel therapies. http://clinicaloptions.com/onc_podcast_audio_heme06_vose.mp3 Tue, 9 Jan 2007 17:00:00 GMT 4:25 hematology, lymphoma, Vose Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Kenneth Anderson, MD, describes the evolving story of myeloma therapy in both front-line and previously treated patients. http://clinicaloptions.com/onc_podcast_audio_heme06_anderson.mp3 Fri, 5 Jan 2007 17:00:00 GMT 5:18 hematology, myeloma, Anderson Clinical Care Options CCO Expert Highlights from the Hematology Meeting in Orlando Hagop M. Kantarjian, MD, highlights the impact of new agents that show promise for treatment of acute leukemia and myelodysplastic syndrome. http://clinicaloptions.com/onc_podcast_audio_heme06_kantarjian.mp3 Fri, 5 Jan 2007 17:00:00 GMT 8:39 hematology, leukemia, Kantarjian Clinical Care Options CCO Expert Highlights from the 2008 Hematology Meeting Hagop Kantarjian, MD, provides an update of presentations on acute myeloid leukemia, myelodysplastic syndromes, and myelofibrosis. http://clinicaloptions.com/onc_podcast_audio_hematology2008_kantarjian.mp3 Mon, 29 Dec 2008 17:00:00 GMT 9:16 hematology, leukemia, Kantarjian Clinical Care Options CCO Expert Highlights from the 2008 Hematology Meeting Kanti Rai, MD, discusses updates in CLL therapies, including lenalidomide in the frontline setting, FCR data from the REACH trial, and the novel agent ofatumumab. http://clinicaloptions.com/onc_podcast_audio_hematology2008_rai.mp3 Mon, 29 Dec 2008 17:00:00 GMT 12:49 hematology, CLL, Rai Clinical Care Options CCO Expert Highlights from the 2008 Hematology Meeting David P. Steensma, MD, describes a patient-level meta-analysis on the effect of ESAs on the survival of cancer patients and the implications for patient care. http://clinicaloptions.com/onc_podcast_audio_hematology2008_Steensma.mp3 Mon, 29 Dec 2008 17:00:00 GMT 8:28 hematology, ESAs, Steensma Clinical Care Options CCO Expert Highlights from the 2008 Hematology Meeting Steven Bernstein, MD, summarizes the clinical advances in improving outcomes in patients with non-Hodgkin’s lymphomas, in particular T-cell lymphomas and mantle cell lymphomas. http://clinicaloptions.com/onc_podcast_audio_hematology2008_Bernstein.mp3 Mon, 29 Dec 2008 17:00:00 GMT 7:13 hematology, Lymphoma, Bernstein Clinical Care Options CCO Expert Highlights from the 2008 Hematology Meeting Sagar Lonial, MD, summarizes the key data presented in San Francisco in multiple myeloma, including updated results from the VISTA trial and from studies in novel agents. http://clinicaloptions.com/onc_podcast_audio_hematology2008_Lonial.mp3 Mon, 29 Dec 2008 17:00:00 GMT 5:12 hematology, Multiple Myeloma, Lonial Clinical Care Options CCO Expert Highlights from the 2008 Breast Cancer Meeting Hope S. Rugo, MD, discusses the highlights of presentations on early breast cancer, including hormone therapy, HER2-directed therapy, use of bisphosphonates to prevent bone loss, and adjuvant therapy. http://clinicaloptions.com/onc_podcast_audio_bc08_Rugo.mp3 Tue, 6 Jan 2009 17:00:00 GMT 11:42 oncology, breast cancer, Rugo Clinical Care Options CCO Expert Highlights from the 2008 Breast Cancer Meeting Kathy D. Miller, MD, reviews the top studies presented for the treatment of metastatic breast cancer including the use of mTOR inhibitors, HDAC inhibitors, antiangiogenic agents, and hormonal therapies. http://clinicaloptions.com/onc_podcast_audio_bc08_Miller.mp3 Tue, 6 Jan 2009 17:00:00 GMT 10:38 oncology, breast cancer, Miller Clinical Care Options CCO Expert Highlights from the 2008 Breast Cancer Meeting William J. Gradishar, MD, FACP, discusses key studies presented on molecular markers and tools for predicting treatment benefit in breast cancer patients. http://clinicaloptions.com/onc_podcast_audio_bc08_Gradishar.mp3 Tue, 6 Jan 2009 17:00:00 GMT 9:08 oncology, breast cancer, Gradishar